Prospective Evaluation of Outcome for Patients with Heart Failure with Preserved Left Ventricular Ejection Fractio

Not Applicable

• Conditions: Heart Failure (HF); Cardiovascular - Other cardiovascular diseases; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12610000374066
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-05-10
• Last Update Posted: 16 February 2021

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 2500

Inclusion Criteria

Patients who either:

a) Present to hospital with a primary diagnosis of heart failure, or

b) Attend a hospital clinic for management of HF within 6 months of diagnosis

Exclusion Criteria

Patients will be excluded from this study if:

a) HF is primarily due to valve disease

b) if the primary diagnosis is an acute coronary syndrome which has resulted in a transient episode of acute pulmonary oedema. (Note: patients with a troponin rise noted during the index admission, but in whom the main presentation is considered clinically to be HF will be included).

c) the patient has end stage renal failure estimated glomerular filtration rate (eGFR)<15ml/min/m2 or is receiving or planned to receive renal replacement therapy

d)constrictive pericarditis

e)other life threatening comorbidity with a life expectancy of <1 year

f)inability to provide informed consent

g)inability to comply with study protocol requirements

Patients who are unable to attend for follow-up will still be considered for the study even if they are not able to undertake the post discharge study visits.

Study & Design

• Study Type: Observational
• Study Design: Not specified